Showing results (681-690 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|October 21, 2003
Efficacy and tolerability of controlled-release paroxetineRobert N GoldenPsychopharmacology Bulletin|October 21, 2003
Alzheimer's disease and the glutamate NMDA receptorP Murali DoraiswamyPsychopharmacology Bulletin|October 21, 2003
Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depressionBrenda D Jamerson, K Ranga Rama Krishnan, Jeremy Roberts, et al.Psychopharmacology Bulletin|January 1, 1992
Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophreniaO M Wolkowitz, N Turetsky, V I Reus, et al.Psychopharmacology Bulletin|January 1, 1992
Risperidone: clinical safety and efficacy in schizophreniaR L Borison, A P Pathiraja, B I Diamond, et al.Psychopharmacology Bulletin|December 17, 2003
DDTC, a metabolite of disulfiram, reduces the stimulating effect on ethanol's locomotor activity in miceMaria Dolores Escarabajal, Carlos M G AragonPsychopharmacology Bulletin|December 17, 2003
Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and updateNunzio Pomara, William M Greenberg, Michael D Branford, et al.Psychopharmacology Bulletin|October 17, 2003
Evidence for the treatment of borderline personality disorderJane P Gagliardi, Ranga R KrishnanPsychopharmacology Bulletin|October 17, 2003
Does isotretinoin cause depression and suicide?J Douglas BremnerPsychopharmacology Bulletin|May 2, 2018
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress DisorderGerardo Villarreal, Mark B Hamner, Clifford Qualls, et al.Pageof 128